Your browser doesn't support javascript.
loading
Serum Vitamin D levels and Vitamin D supplementation do not correlate with the severity of chronic eczema in children.
Galli, E; Rocchi, L; Carello, R; Giampietro, P G; Panei, P; Meglio, P.
Afiliação
  • Galli E; Department of Pediatric Allergy, Research Centre, San Pietro Hospital - Fatebenefratelli, Via Cassia 600, Rome, Italy. Phone: +39 06 335 822 80 Fax: +39 06 332 512 78 E-mail: galli.elena@fbfrm.it.
  • Rocchi L; Department of Pediatric Allergy, Research Centre, San Pietro Hospital - Fatebenefratelli, Rome, Italy.
  • Carello R; Department of Pediatric Allergy, Research Centre, San Pietro Hospital - Fatebenefratelli, Rome, Italy.
  • Giampietro PG; Department of Pediatric Allergy, Research Centre, San Pietro Hospital - Fatebenefratelli, Rome, Italy.
  • Panei P; Dipartimento del Farmaco e Terapie Sperimentali, Istituto Superiore di Sanità, Rome, Italy.
  • Meglio P; Department of Pediatric Allergy, Research Centre, San Pietro Hospital - Fatebenefratelli, Rome, Italy.
Eur Ann Allergy Clin Immunol ; 47(2): 41-7, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25781193
ABSTRACT

BACKGROUND:

Eczema is one of the most common chronic inflammatory skin diseases, affecting about 20% of children. The pathogenic mechanisms of eczema are still not fully understood, and current treatment of moderate-severe eczema is often difficult. Recently, it has been suggested that Vitamin D plays a key role in this disease, even if mechanisms are only partially known.

OBJECTIVE:

The purpose of our study was to assess the 25-Hydroxyvitamin D serum levels in a pediatric population suffering from chronic eczema (IgE-mediated and non-IgE-mediated), and to correlate these phenotypes with the SCORAD severity and selected clinical and biological parameters. Moreover, we aimed to evaluate whether a supplementation of Vitamin D3 could affect the same clinical and laboratory parameters.

METHODS:

89 children with chronic eczema were enrolled in the study. Severity of eczema was assessed with the SCORAD index. Past and present history was taken, and patients were divided into two groups according to the state of sensitization. According to a randomization schedule, the enrolled children were assigned to the following groups supplementation group, which received a daily oral Vitamin D3 supplementation (2000 IUs) for 3 months; control group which received no supplementation.

RESULTS:

Vitamin D concentrations in patients with moderate and severe eczema were not statistically different from Vitamin D concentration detected in the serum of patients with mild eczema. Furthermore, we did not find any correlation between Vitamin D levels, total IgEs and SCORAD index, both in the Sensitized and in the Not-Sensitized group. The Vitamin D3 supplementation did not influence the SCORAD severity or the total IgEs concentration.

CONCLUSION:

To our knowledge, our study is the first one that shows no correlation between serum levels of Vitamin D, eczema severity and IgE sensitization in a pediatric population suffering from chronic eczema.
Assuntos
Palavras-chave
Buscar no Google
Base de dados: MEDLINE Assunto principal: Calcifediol / Suplementos Nutricionais / Eczema Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Calcifediol / Suplementos Nutricionais / Eczema Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article